Literature DB >> 12570124

Urinary leukotriene E4 in preschool children with acute clinical viral wheeze.

A Oommen1, J Grigg.   

Abstract

Cysteinyl leukotrienes (cystLTs) are important mediators of wheeze in atopic asthma, but the role of cystLTs in the pathogenesis of preschool viral wheeze (PVW) is unclear. Therefore, evidence for increased production of cystLTs in PVW was sought. Urinary leukotriene E4 (uLTE4) and serum total immunoglobulin (Ig)E were measured in children (1-5 yrs) with PVW during an acute attack (n=44) and in the convalescent phase (n=19), and compared with normal controls (n=15). The effect of atopic sensitisation was assessed in a separate group of atopic controls (n=6) in whom only uLTE4 was measured. The levels of uLTE4 were similar in normal and atopic controls and increased in acute PVW (median (interquartile range) 165 (101-285) versus 125 (82-163) ng x mM creatinine(-1)). Stratification by IgE showed that whereas uLTE4 was increased in 23 children with acute PVW and IgE > 95th percentile (median 211 (118-312) ng x mM creatinine(-1)), uLTE4 was not increased in the 21 children with acute PVW and IgE < or = 95th percentile. In the convalescent phase, uLTE4 fell in the subgroup with high IgE but not in the subgroup with low IgE. It is concluded that increased cysteinyl leukotriene production during acute preschool viral wheeze is associated with high serum immunoglobulin E.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12570124     DOI: 10.1183/09031936.02.00021202

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Eosinophil activation and preschool viral wheeze.

Authors:  A Oommen; T McNally; J Grigg
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

2.  Systemic neutrophil activation in acute preschool viral wheeze.

Authors:  A Oommen; R Patel; M Browning; J Grigg
Journal:  Arch Dis Child       Date:  2003-06       Impact factor: 3.791

Review 3.  Management of preschool recurrent wheezing and asthma: a phenotype-based approach.

Authors:  Avraham Beigelman; Leonard B Bacharier
Journal:  Curr Opin Allergy Clin Immunol       Date:  2017-04

4.  Montelukast in asthma: a review of its efficacy and place in therapy.

Authors:  Pierluigi Paggiaro; Elena Bacci
Journal:  Ther Adv Chronic Dis       Date:  2011-01       Impact factor: 5.091

5.  Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma.

Authors:  Chang Cai; Jiong Yang; Suping Hu; Meiqian Zhou; Wei Guo
Journal:  Lung       Date:  2007-03-28       Impact factor: 2.584

Review 6.  Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.

Authors:  Malcolm Brodlie; Atul Gupta; Carlos E Rodriguez-Martinez; Jose A Castro-Rodriguez; Francine M Ducharme; Michael C McKean
Journal:  Cochrane Database Syst Rev       Date:  2015-10-19

7.  Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial.

Authors:  Chinedu Nwokoro; Hitesh Pandya; Stephen Turner; Sandra Eldridge; Christopher J Griffiths; Tom Vulliamy; David Price; Marek Sanak; John W Holloway; Rossa Brugha; Lee Koh; Iain Dickson; Clare Rutterford; Jonathan Grigg
Journal:  Lancet Respir Med       Date:  2014-09-08       Impact factor: 30.700

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.